StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

GSK ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was £10.25B, up 55.9% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is £11.95B in fiscal 2015.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025£10.25B+55.9%
FY2024Dec 31, 2024£6.57B-27.3%
FY2023Dec 31, 2023£9.04B+5.3%
FY2022Dec 31, 2022£8.58B+32.4%
FY2021Dec 31, 2021£6.48B-19.3%
FY2020Dec 31, 2020£8.03B-13.6%
FY2019Dec 31, 2019£9.30B+26.7%
FY2018Dec 31, 2018£7.34B+22.1%
FY2017Dec 31, 2017£6.01B+37.4%
FY2016Dec 31, 2016£4.37B-63.4%
FY2015Dec 31, 2015£11.95B–

More GSK figures

See a number that looks wrong?